ERVMER34-1: A Drug Target / Disease Biomarker (G100288413)

Target Name: ERVMER34-1

NCBI ID: G100288413

ERVMER34-1

Other Name(s): MER34_HUMAN | endogenous retrovirus group MER34 member 1, envelope | Human endogenous MER34 (medium-reiteration-frequency-family-34) open reading frame | ERVMER34-1 variant 1 | HERV-MER_4q12 provirus ancestral Env polyprotein | Endogenous retroviral envelope protein HEMO, 48 kDa form | Human endogenous MER34 ORF | endogenous retrovirus group MER34, member 1 | Endogenous retroviral envelope protein HEMO | endogenous MER34 (medium-reiteration-frequency-family-34) ORF | LP9056 protein | human endogenous MER34 ORF | endogenous retrovirus group MER34 member 1 Env polyprotein | endogenous retrovirus group MER34 member 1 | HEMO | envMER34 | Endogenous retroviral envelope protein HEMO, secreted form | Endogenous retrovirus group MER34 member 1, envelope, transcript variant 1

ERVMER34-1: A Drug Target / Disease Biomarker

ERVMER34-1 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the cell division process, and is involved in the development and maintenance of tissues such as the brain, heart, and blood vessels.

Research has suggested that ERVMER34-1 may have potential as a drug target or biomarker. One reason for this is that the protein is known to interact with several different drugs, including those that are used to treat a variety of diseases. For example, studies have shown that ERVMER34-1 can interact with compounds that are used to treat cancer, heart disease, and neurological disorders.

Additionally, ERVMER34-1 has been shown to play a role in the development of certain diseases. For example, studies have shown that high levels of ERVMER34-1 are associated with an increased risk of certain types of cancer, such as breast cancer and lung cancer.

Furthermore, ERVMER34-1 has also been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues. For example, studies have shown that ERVMER34-1 is involved in the regulation of cell division, cell migration, and the formation of blood vessels.

Overall, ERVMER34-1 is a protein that has potential as a drug target or biomarker. Further research is needed to fully understand its role in the development and maintenance of tissues, and to determine its potential as a therapeutic agent.

Protein Name: Endogenous Retrovirus Group MER34 Member 1, Envelope

Functions: Endogenous envelope proteins originate from retroviral envelope proteins, which mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution

The "ERVMER34-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ERVMER34-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets